How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Consumer Goods and Retail · Forecast 2027–2033
Gurneys Market
- By Product Type: Outdoor Gurneys, Indoor Gurneys, Adjustable Gurneys, Fixed Height Gurneys, Specialty Gurneys
- By Material: Steel Frame Gurneys, Aluminum Frame Gurneys, Wooden Frame Gurneys, Plastic Composite Gurneys
- By Mobility Features: Wheeled Gurneys, Stationary Gurneys, Locking Wheel Gurneys, Swivel Wheel Gurneys
- By Load Capacity: Light-Duty Gurneys, Medium-Duty Gurneys, Heavy-Duty Gurneys
- By Application: Hospital Use Gurneys, Emergency Medical Services (EMS) Gurneys, Patient Transport Gurneys, Surgical Gurneys
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Outdoor Gurneys leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 24 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 315 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 24 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Gurneys Market report
A complete, evidence-based study - 12 chapters and 132 sections covering market size, segmentation across 5 axes, regional analysis and 24 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
24 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Stryker
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Slumberjack
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Acme United Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Alimed
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Arjo
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GF Health Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Natus Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →DRE Medical Equipment
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.196 →Ferno-Washington
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.202 →Future Health Concepts
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.209 →Graham Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Gumbo Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →MJM International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Monet Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.232 →Nasco Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.238 →Newmatic Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.245 →Pedigo Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.250 →Piedmont Medical Inc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.256 →ReMed Services LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.263 →Soma Technology
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.268 →Taylor Healthcare Products
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.274 →The Alternative Source Medical LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.281 →Auxo Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.286 →Detecto
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.292 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Outdoor Gurneys56.8
- Indoor Gurneys13.3
- Adjustable Gurneys9.9
- Fixed Height Gurneys11.0
- Specialty Gurneys8.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Stryker25.1
- Slumberjack23.7
- Acme United Corporation6.2
- Alimed4.5
- Arjo6.0
- GF Health Products6.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.0
- Europe20.4
- Asia Pacific21.4
- Latin America13.2
- Middle East and Africa8.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Stryker | 86 | 84 | 85 | 94 | 89 | 89 | 88 |
| Slumberjack | 93 | 87 | 74 | 90 | 85 | 78 | 85 |
| Acme United Corporation | 80 | 79 | 77 | 72 | 81 | 79 | 78 |
| Alimed | 63 | 81 | 64 | 59 | 60 | 59 | 64 |
| Arjo | 55 | 60 | 75 | 52 | 74 | 61 | 63 |
| GF Health Products | 49 | 47 | 66 | 51 | 49 | 48 | 52 |
| Natus Medical | 43 | 60 | 46 | 56 | 53 | 66 | 54 |
| DRE Medical Equipment | 55 | 48 | 49 | 44 | 56 | 54 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Stryker
- Slumberjack
- Acme United Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Stryker | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Slumberjack | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Acme United Corporation | ✓ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Alimed | − | ◐ | − | − | ◐ | − |
| Arjo | ◐ | − | ◐ | − | ◐ | ◐ |
| GF Health Products | − | ◐ | ◐ | − | ◐ | − |
| Natus Medical | − | ◐ | − | ◐ | − | ◐ |
| DRE Medical Equipment | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Contender2
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Product Type in North America, then scale across Gurneys Market — a $493M beachhead inside a $7.95B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Outdoor Gurneys
Best fit — highest urgency & budget in Product Type.
Indoor Gurneys
Strong fit — clear ROI and a fast path to value.
Adjustable Gurneys
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Mobility Features
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Gurneys Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Gurneys Market is a high-growth opportunity — $4.98B by 2033, compounding at 10.8%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
24+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Gurneys Market — a $4.63B market by 2033. Plan: grow share from 7.9% to 15.4%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 15.4% | On track |
| Revenue | $399M | $713M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.7% | 43.7% | Behind |
| Customer retention | 86.7% | 96.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $86M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Sales deck · value proposition
Win the Gurneys Market conversation — a $7.30B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Gurneys Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Gurneys Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Consumer Goods and Retail · scroll →Guqin Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportParaphenylenediamine Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportGummy Candies Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportGuitar Tuner Pedal Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportGuitar Tube Amplifiers Market
Guitar Tube Amplifiers Market is valued at USD 1.25 Billion in 2025 and is expected to reach US…
$1.3B market · 2025 base year
View reportGuitar Speaker Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportGuitar Solid State Amplifiers Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportGuitar Looper Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportGuitar Hybrid Amplifiers Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportGuitar Head Amplifiers Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportGuitar Electronic Amplifiers Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportGuitar Electric Box Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy